1. |
Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia, 2008, 14: 1229-1239.
|
2. |
Pabinger I, Thaler J. How I treat patients with hereditary antithrombin deficiency. Blood, 2019, 134(26): 2346-2353.
|
3. |
Bravo-Pérez C, Vicente V, Corral J. Management of antithrombin deficiency: an update for clinicians. Expert Rev Hematol, 2019, 12: 397-405.
|
4. |
de la Morena-Barrio B, Orlando C, de la Morena-Barrio ME, et al. Incidence and features of thrombosis in children with inherited antithrombin deficiency. Haematologica, 2019, 104: 2512-2518.
|
5. |
Croles FN, Borjas-Howard J, Nasserinejad K, et al. Risk of venous thrombosis in antithrombin deficiency: a systematic review and Bayesian meta-analysis. Semin Thromb Hemost, 2018, 44: 315-326.
|
6. |
Corral J, de la Morena-Barrio ME, Vicente V. The genetics of antithrombin. Thromb Res, 2018, 169: 23-29.
|
7. |
Mahmoodi BK, Brouwer JL, Ten Kate MK, et al. A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. J Thromb Haemost, 2010, 8: 1193-1200.
|
8. |
Ahmad A. Genetics of cerebral venous thrombosis. J Pak Med Assoc, 2006, 56(11): 488-490.
|
9. |
Eastwood KA, Vaughan A, McCune KH. Mesenteric vein thrombosis associated with anti-thrombin III deficiency. Ulster Med J, 2009, 78(1): 53-55.
|
10. |
Roldán V, Ordoñez A, Marín F, et al. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis. Thromb Haemost, 2009, 101: 483-486.
|
11. |
Mulder R, Croles FN, Mulder AB, et al. SERPINC1 gene mutations in antithrombin deficiency. Br J Haematol, 2017, 178: 279-285.
|
12. |
de la Morena-Barrio ME, Wypasek E, Owczarek D, et al. MPI-CDG with transient hypoglycosylation and antithrombin deficiency. Haematologica, 2019, 104: e79-e82.
|
13. |
Skelley JW, White CW, Thomason AR. The use of direct oral anticoagulants in inherited thrombophilia. J Thromb Thrombolysis, 2017, 43: 24-30.
|
14. |
Kawano H, Maemura K. Edoxaban was effective for the treatment of deep vein thrombosis and pulmonary thromboembolism in a cancer patient with antithrombin III deficiency. Intern Med, 2016, 55(22): 3285-3289.
|
15. |
Minami K, Kumagai K, Sugai Y, et al. Efficacy of oral factor Xa inhibitor for venous thromboembolism in a patient with antithrombin deficiency. Intern Med, 2018, 57(14): 2025-2028.
|
16. |
Witters P, Cassiman D, Morava E. Nutritional therapies in congenital disorders of glycosylation (CDG). Nutrients, 2017, 9(11): 1222.
|